We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+6.56%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.19B
AUM Growth
+$87.3M
Cap. Flow
-$32.3M
Cap. Flow %
-1.47%
Top 10 Hldgs %
16.38%
Holding
3,048
New
77
Increased
389
Reduced
606
Closed
84

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$4.67M
2
VZ icon
Verizon
VZ
+$4.4M
3
AAPL icon
Apple
AAPL
+$3.54M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$3.35M
5
AVGO icon
Broadcom
AVGO
+$3.22M

Sector Composition

Rank Sector Weight
1 Technology 13.17%
2 Financials 12.66%
3 Industrials 10.63%
4 Healthcare 8.88%
5 Consumer Discretionary 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GCAP
2201
DELISTED
Gain Capital Holdings, Inc.
GCAP
$31K ﹤0.01%
3,144
UCFC
2202
DELISTED
United Community Financial Corp
UCFC
$31K ﹤0.01%
3,416
WIN
2203
DELISTED
Windstream Holdings Inc
WIN
$31K ﹤0.01%
3,347
QADA
2204
DELISTED
QAD Inc.
QADA
$31K ﹤0.01%
789
BRK.A icon
2205
Berkshire Hathaway Class A
BRK.A
$1.11T
$30K ﹤0.01%
5
CHEF icon
2206
Chefs' Warehouse
CHEF
$4.46B
$30K ﹤0.01%
1,456
CHRS icon
2207
Coherus Oncology
CHRS
$187M
$30K ﹤0.01%
3,367
CSV icon
2208
Carriage Services
CSV
$534M
$30K ﹤0.01%
1,152
CYTK icon
2209
Cytokinetics
CYTK
$10.6B
$30K ﹤0.01%
3,647
HCKT icon
2210
Hackett Group
HCKT
$285M
$30K ﹤0.01%
1,931
PBE icon
2211
Invesco Biotechnology & Genome ETF
PBE
$358M
$30K ﹤0.01%
45
RDNT icon
2212
RadNet
RDNT
$6.01B
$30K ﹤0.01%
2,930
PCSB
2213
DELISTED
PCSB Financial Corporation
PCSB
$30K ﹤0.01%
1,589
AXAS
2214
DELISTED
Abraxas Petroleum Corp
AXAS
$30K ﹤0.01%
617
STML
2215
DELISTED
Stemline Therapeutics, Inc.
STML
$30K ﹤0.01%
1,930
+617
+47% +$8.25K
SN
2216
DELISTED
Sanchez Energy Corporation
SN
$30K ﹤0.01%
5,640
APPF icon
2217
AppFolio
APPF
$7.19B
$29K ﹤0.01%
701
ATEN icon
2218
A10 Networks
ATEN
$1.97B
$29K ﹤0.01%
3,806
BBH icon
2219
VanEck Biotech ETF
BBH
$428M
$29K ﹤0.01%
50
CIO
2220
DELISTED
City Office REIT
CIO
$29K ﹤0.01%
2,250
CLDX icon
2221
Celldex Therapeutics
CLDX
$3.48B
$29K ﹤0.01%
690
+183
+36% +$7.84K
FMNB icon
2222
Farmers National Banc Corp
FMNB
$952M
$29K ﹤0.01%
1,937
INO icon
2223
Inovio Pharmaceuticals
INO
$79.1M
$29K ﹤0.01%
578
+129
+29% +$8K
LE icon
2224
Lands' End
LE
$402M
$29K ﹤0.01%
1,477
MLAB icon
2225
Mesa Laboratories
MLAB
$622M
$29K ﹤0.01%
233

Similar funds

Ameritas Investment Partners's Q4 2017 Portfolio in Review

As of Q4 2017, Ameritas Investment Partners held 3,048 positions worth $2.19B, up 4.1% from $2.11B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Ameritas Investment Partners's Q4 2017 filing shows 77 new, 389 increased, 606 reduced and 84 closed positions. Its largest new stake was Knight Transportation: 48,927 shares worth $2.14M. The largest sale was Visa, an estimated $4.67M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Financials and Industrials.

  • Ameritas Investment Partners's largest Q4 2017 buy was Knight Transportation: 48,927 shares worth $2.14M.
  • Ameritas Investment Partners added most to Alerian MLP ETF in Q4 2017, an estimated $16.4M increase.
  • Ameritas Investment Partners's biggest Q4 2017 reduction was Visa, cutting an estimated $4.67M.
  • Ameritas Investment Partners fully exited VCA Inc. in Q4 2017, selling an estimated $2.26M.
  • Ameritas Investment Partners's ten largest holdings make up 16% of its $2.19B portfolio in Q4 2017.
  • Ameritas Investment Partners opened 77 new positions and closed 84 in Q4 2017.
  • Ameritas Investment Partners's portfolio value rose 4.1% quarter-over-quarter to $2.19B.

Based on Ameritas Investment Partners's 13F filing for Q4 2017, filed 14 Feb 2018.